Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Maxalt for early mild migraine
NCT00092963Phase 3Completed
- Sponsor
- Organon & Co.
- Start
- Aug 2004
- Primary completion
- Jan 2005
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of rizatriptan in migraine, sponsored by Organon & Co.. Started Aug 2004; status: completed.
02
Drugs
rizatriptan
03
Conditions
migraine
Beyond the preview
Go deeper on NCT00092963.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00092963.